Abstract
Seven patients with glioblastoma multiforme received 2-hour intravenous infusions of p-boronophenylalanine (BPA) prior to craniotomy. The BPA was solubilized for injection by complexation with fructose. Administered BPA doses were 100mg BPA/kg (n=1), 130 mg BPA/kg (n=5) and 170 mg BPA/kg (n=1). The boron concentration in blood was proportional to the administered dose. The boron concentrations in scalp were 1-2 times higher than the corresponding boron concentration in the blood. The boron concentrations in the tumor (range, 11–26µg 10B/g) were from 1–4 times the corresponding levels in the blood.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L.E. Farr, W.H. Sweet, J.S. Robertson, C.G. Foster, H.B. Locksley, D.L. Suntherland, M.L. Mendelsohn and E.E. Stickly, Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Am. J. Roentgenol. 71: 279–291, 1954.
H. Hatanaka and Y. Nakagawa, Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28: 1061–1066, 1994.
Y. Mishima, C. Honda, M. Ichihashi, H. Obara, J. Hiratsuka, H. Fukuda, H. Karashima, T. Kobayashi, K. Kanda and K. Yoshino, Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking IOB compound. Lancet 12: 388–389, 1989.
Y. Mishima, M. lchihashi, C. Honda, M. Shiono, T. Nakagawa, H. Obara, J. Shirakawa, J. Hiratsuka, K. Kanda, T. Kobayashi, T. Nozaki, O. Aigawa, T. Sato, H. Karashima, K. Yoshino and H. Fukuda, Advances in the control of cutaneous primary and metastatic melanoma by thermal neutron capture therapy. in: “Progress in Neutron Capture Therapy for Cancer,” B. Allen, D. Moore and B. Harrington, ed., Plenum Press, New York, 1992, pp 577–583.
H. Fukuda, J. Hiratsuka, C. Honda, T. Kobayashi, K. Yoshino, H. Karashima. J. Takahashi, Y. Abe, K. Kanda, M. Ichihashi and Y. Mishima, Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat. Res. 138: 435–442, 1994.
J.A. Coderre, D.D. Joel, P.L. Micca, M.M. Nawrocky and D.N. Slatkin, Control of intracerebral gliosarcoma in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat. Res. 129: 290296, 1992.
K. Yoshino, A. Suzuki, Y. Mori, H. Kanihana, C. Honda, Y. Mishima, T. Kobayashi and K. Kanda, Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlentherapie und Oncologie 165: 127–129, 1989.
T. Lahann, D. Lu, C. Sills, G, Daniell, S. Kraft, P. Gavina and W. Bauer, Bioavailability of intravenous formulations of p-boronophenylalanine. in: “Advances in Neutron Capture Therapy,” A. Soloway, R. Barth and D. Carpenter, ed., Plenum Press, New York, 1993, pp 513–517.
R. Fairchild, D. Gabel, B. Laster, D. Greenberg, W. Kiszenick and P. Micca, Microanalytical techniques for boron analysis using the lOB(n,a)7Li reaction. Med. Phys. 13: 50–56, 1986.
Y. Mishima, M. Ichihashi and T. Nakanishi, Cure of malignant melanoma by single thermal neutron capture treatment using melanoma seeking compounds: l OB/melanogenesis interaction to in vitro/in vivo radiobiological analysis to preclinical studies. in: “Proceedings of the First International Symposium on Neutron Capture Therapy,” R. Fairchild and G. Brownell, ed., Brookhaven National Laboratory, Upton, 1983, pp 355–364.
J. Coderre, J. Glass, R. Fairchild, P. Micca, I. Fand and D. Joel, Selective delivery of boron by the melanin precursor analog p-boronophenylalanine to tumors other than melanoma. Cancer Res. 50: 138–141, 1990.
J. Coderre, M. Makar, P. Micca, M. Nawrocky, H. Liu, D. Joel, D. Slatkin and H. Amols, Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys. 27: 1121–1129, 1993.
Y. Mori, A. Suzuki, K. Yoshino and H. Kanihana, Complex formation of p-boronophenylalanine with some monosaccharides. Pigment Cell Research 2: 273–277, 1989.
J. Coderre, A phase 1 biodistribution study of p-boronophenylalanine. in: “Boron Neutron Capture Therapy: Towards Clinical Trials of Glioma with BNCT,” R. Moss and D. Gabel, ed.,. Plenum Press, New York, 1992, pp 111–121.
J. Mallesch, D. Moore, B. Allen, W. McCarthy, R. Jones and W. Stening, The pharmacokinetics of p-boronophenylalanine-fructose in human patients with glioma and metastatic melanoma. Int. J. Radiat. Oncol. Biol. Phys. 28: 1183–1188, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bergland, R., Elowitz, E., Coderre, J.A., Joel, D., Chadha, M. (1996). A Phase 1 Trial of Intravenous Boronophenylalanine-Fructose Complex in Patients with Glioblastoma Multiforme. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_105
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_105
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive